课题基金 / 基金详情

Preserving the immunoprivilege of transplanted allogeneic mesenchymal stem cells in the ischemic heart

Preserving the immunoprivilege of transplanted allogeneic mesenchymal stem cells in the ischemic heart
保护缺血心脏中移植的同种异体间充质干细胞的免疫特权
批准号:
321665
负责人:
Dhingra Sanjiv
金额:
$37.97万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-03-01 至 2020-03-01

项目摘要

项目成果

Dhingra Sanjiv的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Heart disease is one of the leading causes of death in Canada. Unfortunately there are no effective therapies available that can provide permanent solution to the problem. Identifying, new research approaches that can offer potentially curative therapies
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determinants of immunogenicity of allogeneic mesenchymal stem cells in the ischemic heart
Role of COP 9 signalosome subunit 5 in preserving immunoprivilege of allogeneic mesenchymal stem cells in the ischemic heart
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
海外基金